as on November 5, 2025 at 2:29 am IST
Day's Low
Day's High
0.31%
Downside
2.92%
Upside
52 Week's Low
52 Week's High
5.07%
Downside
164.67%
Upside
Check Organon & Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
3.8489
Dividend Yield
4.92%
Quarterly Earnings Growth YOY
-0.26%
PE Ratio (TTM)
2.49
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
1.7B
Revenue (TTM)
6.3B
Profit Margin
11.15%
Return On Equity TTM
159.64%
Track how Organon & Co. P/E has moved over time to understand its valuation trends.
Organon & Co. in the last 5 years
Lowest (2.55x)
September 30, 2025
Today (2.49x)
November 5, 2025
Industry (8.36x)
November 5, 2025
Highest (9.44x)
June 30, 2021
Today’s Price to Earnings Ratio: 2.49x
Compare market cap, revenue, PE, and other key metrics of Organon & Co. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | NA | 2.49 | 11.15% | |
| BUY | $802.4B | 523.19% | 43.86 | 30.99% | |
| BUY | $374.4B | 130.43% | 161.8 | 4.00% | |
| BUY | $448.8B | 33.7% | 17.98 | 27.26% | |
| BUY | $217.5B | 34.85% | 12.76 | 35.61% |
The Organon & Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Organon & Co. investment value today
Current value as on today
₹45,198
Returns
Returns from Organon & Co. Stock
Dollar Returns*
₹5,648 (+5.65%)
Based on 14 analysts
50.00%
Buy
42.86%
Hold
7.14%
Sell
Based on 14 analysts, 50% of analysts recommend a 'BUY' rating for Organon & Co.. Average target price of $10.83
Get share price movements and forecasts by analysts on Organon & Co..
What analysts predicted
39.89%UPSIDE
Target Price
$10.83
Current Price
$6.51
Analyzed by
14 Analysts
Target
$10.83
Organon & Co. target price $10.83, a slight upside of 39.89% compared to current price of $6.51. According to 14 analysts rating.
Investment in Organon & Co. Shares on INDmoney has grown by 1266.66% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1266.66% versus previous 30 day period
Search interest for Organon & Co. Stock has increased by 142% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:142% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 27 October
Mon, 05:00 PM
-Organon announces CEO Kevin Ali's resignation following an internal investigation into improper sales practices for Nexplanon contraceptive implant.
Mon, 10:59 PM
-Shares of Organon plummet 22% after CEO resignation and investigation findings regarding sales practices.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 1.51B → 1.59B (in $), with an average increase of 5.1% per quarter
Price Rise
![]()
In the last 7 days, OGN stock has moved up by 5.8%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 87.0M → 145.0M (in $), with an average increase of 40.0% per quarter
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 17.6% return, outperforming this stock by 76.8%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 8.6% return, outperforming this stock by 81.0%
| Organisation | Organon & Co. |
| Headquarters | 30 Hudson Street, Jersey City, NJ, United States, 07302 |
| Industry | Healthcare |
| CEO | Mr. Joseph T. Morrissey Jr. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Daniel Karp | Head of Corporate Development |
Mr. Aaron Falcione | Executive VP & Chief Human Resources Officer |
Mr. Vittorio Nisita | Executive VP & Head of Enterprise Services and Solutions |
Ms. Carrie Smith Cox | Interim Executive Chairman of the Board |
Mr. Matthew M. Walsh C.F.A. | Executive VP & CFO |
Ms. Jennifer Halchak | Head of Investor Relations |
Mr. Kirke Weaver | Executive VP, General Counsel & Corporate Secretary |
Ms. Rachel A. Stahler | Chief Digital & Commercial Innovation Officer |
Mr. Joseph T. Morrissey Jr. | Interim CEO & Executive VP and Head of Manufacturing & Supply |
Dr. Juan Camilo Arjona Ferreira M.D. | Executive VP, Head of Research & Development and Chief Medical Officer |
Organon & Co. share price today is $6.51 as on at the close of the market. Organon & Co. share today touched a day high of $6.7 and a low of $6.49.
Organon & Co. share touched a 52 week high of $17.23 on and a 52 week low of $6.18 on . Organon & Co. stock price today i.e. is closed at $6.51,which is 62.22% down from its 52 week high and 5.34% up from its 52 week low.
Organon & Co. market capitalisation is $0.00T as on .
Indian investors can start investing in Organon & Co. (OGN) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Organon & Co. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Organon & Co. share’s latest price of $6.51 as on November 5, 2025 at 2:29 am IST, you will get 1.5361 shares of Organon & Co.. Learn more about
fractional shares .